Recombinant Human C1 Esterase Inhibitor as Short-Term Prophylaxis for Dental Procedures in Patients With Angioedema: A Case Series - 05/02/19
Doi : 10.1016/j.jaci.2018.12.113
Anna Valerieva, MD 1, Maria T. Staevska, MD, PhD 2, Milos Jesenak, MD PhD MSc MHA 3, Katarina Hrubiskova 4, Marta Sobotkova 5, Radana Zachova 5, Roman Hakl 6, Sladjana Andrejevic 7, Tobias M. Suiter, MD 8, Vesna Grivcheva-Panovska 9, Ljerka Karadza-Lapic 10, Ralph Shapiro, MD 11, Florence Ida Hsu, MD FAAAAI 12, Andrea Zanichelli 13
1 Medical University of Sofia, Sofia, Bulgaria
2 University Hospital Alexandrovska, Sofia, Bulgaria
3 Comenius University in Bratislava, Martin, Slovakia
4 Bratislava University Hospital, Bratislava, Slovakia
5 2nd Medical School Charles University and University Hospital Motol, Prague, Czech Republic
6 Dept Clin Immunol. Al, Faculty hospital u sv. Anny v Brne, Brno, Czech Republic
7 Clinical Center of Serbia, Belgrade, Serbia
8 Pharming Group NV, Leiden, Netherlands
9 University Ss Cyril and Methodius School of Medicine Department of Dermatology, Skopje, Macedonia
10 General Hospital Sibenik, Sibenik, Croatia
11 Midwest Immunology Clinic, Plymouth, MN
12 Yale University School of Medicine, New Haven, CT
13 Department of Biomedical and Clinical Sciences, ASST Fatebenefratelli-Sacco, University of Milan, Luigi Sacco Hospital, Milan, Italy
111
Le texte complet de cet article est disponible en PDF.Plan
© 2018
Publié par Elsevier Masson SAS.
Vol 143 - N° 2S
P. AB37 - février 2019 Retour au numéro
Article précédent
- Oral Plasma Kallikrein Inhibitor BCX7353 is Safe and Effective as an On-Demand Treatment of Angioedema Attacks in Hereditary Angioedema (HAE) Patients: Results of the ZENITH-1 Trial
- Hilary Longhurst, Dumitru Moldovan, Anette Bygum, Marco Cicardi, Aarnoud Huissoon, Emel Aygoren-Pursun, Vesna Grivcheva-Panovska, David Hagin, Urs Steiner, Marcin Stobiecki, Werner Aberer, Claire Bethune, Saul N. Faust, Sorena Kiani, David Launay, Marcus Maurer, William Rae, Avner Reshef, Melanie T. Cornpropst, Sylvia M. Dobo, Sharon VanDyke, Sharon Murray, Phillip J. Collis, William P. Sheridan, Henriette Farkas
- Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study
- Marc A. Riedl, John T. Anderson, Marco Cicardi, H. Henry Li, Richard F. Lockey, Hilary Longhurst, Marcus Maurer, Peng Lu, James Hao, Aleena Banerji
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?